Loading clinical trials...

The Efficacy of Preseasonal Omalizumab Treatment | Clinical Trials | Clareo Health

COMPLETEDNANCT04489121

The Efficacy of Preseasonal Omalizumab Treatment

Allergic rhinitis (AR) is induced by an immunoglobulin E (IgE)-mediated reaction in the allergen-sensitized subjects, affecting 10% to 40% of the world population. AR could be divided into two kinds, ...

Lead sponsor: Beijing Tongren Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

NCT04815668 · Seasonal Allergic Rhinitis

RECRUITINGPhase 2/3

Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

NCT06846385 · Seasonal Allergic Rhinitis

Active Not RecruitingPhase 2

A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

NCT06837233 · Seasonal Allergic Rhinitis

COMPLETEDPhase 2

Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult

NCT06046391 · Seasonal Allergic Rhinitis

COMPLETEDPhase 1

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

NCT03570957 · Seasonal Allergic Rhinitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 28, 2021Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateJul 2020

Last updatedJan 28, 2021

Condition

Seasonal Allergic Rhinitis

Locations shown

Beijing Tongren Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions